Why the study?
Do biomarkers improve cardiovascular risk prediction in older asymptomatic adults?
Do biomarkers improve cardiovascular risk prediction in older asymptomatic adults?
Answers are grounded in this paper and cite their sources.
This paper discusses the use of biomarkers and multivariate risk models for cardiovascular disease risk prediction in older asymptomatic adults.
Estimation of cardiovascular disease (CVD) risk is of paramount importance for the design of primary prevention strategies. Several multivariate risk models have been developed for CVD risk calculation in asymptomatic adults based upon assessment of multiple variables that cause a graded increase in risk.
No takes yet. Share an insight, caveat, or question.
Briasoulis et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: